Patents by Inventor Jean-Philippe Camdessanche

Jean-Philippe Camdessanche has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-ARGONAUTE PROTEIN AUTOANTIBODIES AS BIOMARKERS OF AUTOIMMUNE NEUROLOGICAL DISEASES
    Publication number: 20230314426
    Abstract: The invention relates to a process for identifying patients affected by an autoimmune neurological disease, comprising a step of detection of at least one type of anti-Argonaute autoantibodies (AGO-Abs) in a biological sample of an individual susceptible to be affected by said disease, wherein positive detection of said at least one type of AGO-Abs means that said individual is affected by said autoimmune neurological disease.
    Type: Application
    Filed: September 14, 2021
    Publication date: October 5, 2023
    Inventors: Le Duy DO, Jerome HONNORAT, Anne-Laurie PINTO, Christian Peter MORITZ, Jean-Christophe ANTOINE, Jean-Philippe CAMDESSANCHE, Sergio MUNIZ-CASTRILLO
  • Fibroblast growth factor receptors as diagnostic markers of acquired sensory neuronopathies
    Patent number: 10539577
    Abstract: The present invention relates to the diagnosis of acquired sensory neuronopathies (SNN), and to the treatment of these disorders.
    Type: Grant
    Filed: July 26, 2017
    Date of Patent: January 21, 2020
    Assignees: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE JEAN MONNET SAINT ETIENNE, UNIVERSITE CLAUDE BERNARD LYON 1, HOSPICES CIVILS DE LYON, CENTRE HOSPITALIER UNIVERSITAIRE DE SAINT ETIENNE
    Inventors: Jerome Marc Claude Honnorat, Jean-Christophe Antoine, Jean-Philippe Camdessanche, Nadia Boutahar, Veronique Annie Rogemond
  • FIBROBLAST GROWTH FACTOR RECEPTORS AS DIAGNOSTIC MARKERS OF ACQUIRED SENSORY NEURONOPATHIES
    Publication number: 20170343564
    Abstract: The present invention relates to the diagnosis of acquired sensory neuronopathies (SNN), and to the treatment of these disorders.
    Type: Application
    Filed: July 26, 2017
    Publication date: November 30, 2017
    Inventors: Jerome Marc Claude HONNORAT, Jean-Christophe ANTOINE, Jean-Philippe CAMDESSANCHE, Nadia BOUTAHAR, Veronique Annie ROGEMOND
  • Fibroblast growth factor receptors as diagnostic markers of acquired sensory neuronopathies
    Patent number: 9766253
    Abstract: The present invention relates to the diagnosis of acquired sensory neuronopathies (SNN), and to the treatment of these disorders.
    Type: Grant
    Filed: June 28, 2013
    Date of Patent: September 19, 2017
    Assignees: Institut National de la Sante et de la Recherche Medicale (INSERM), Centre National de la Recherche Scientifique, Universite Jean Monnet, Universite Claude Bernard Lyon 1, Hospices Civils de Lyon, Centre Hospitalier Universitaire de Saint Etienne
    Inventors: Jerome Marc Claude Honnorat, Jean-Christophe Antoine, Jean-Philippe Camdessanche, Nadia Boutahar, Veronique Annie Rogemond
  • FIBROBLAST GROWTH FACTOR RECEPTORS AS DIAGNOSTIC MARKERS OF ACQUIRED SENSORY NEURONOPATHIES
    Publication number: 20150192594
    Abstract: The present invention relates to the diagnosis of acquired sensory neuronopathies (SNN), and to the treatment of these disorders.
    Type: Application
    Filed: June 28, 2013
    Publication date: July 9, 2015
    Inventors: Jerome Marc Claude Honnorat, Jean-Christophe Antoine, Jean-Philippe Camdessanche, Nadia Boutahar, Veronique Annie Rogemond